ישראל -
עברית -
Ministry of Health
נפרוסן
trima israel pharmaceutical products maabarot ltd - naproxen sodium - טבליה - naproxen sodium 275 mg - naproxen - naproxen - mild and moderate analgesic. fever reduction. non-steroidal anti-inflammatory for the treatment of rheumatic inflammations, tendinitis and muscoloskeletal inflammations. treatment of primary dysmenorrhea.
ישראל -
עברית -
Ministry of Health
דפאלפט סירופ
cts chemical industries ltd, israel - valproic acid as sodium - סירופ - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.
ישראל -
עברית -
Ministry of Health
סיסטיין יו.אל
lapidot medical import and marketing ltd - polyethylene glycol 400 0.4 %; propylene glycol 0.3 % - ophthalmic solution - other ophthalmologicals - lubricant eye drops for the temporary relief of burning and irritation due to dryness of the eye.
ישראל -
עברית -
Ministry of Health
מירסרה 30 מק"ג/0.3 מ"ל
roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 30 mcg/ml / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic kidney disease (ckd).
ישראל -
עברית -
Ministry of Health
מירסרה 120 מק"ג/0.3 מ"ל
roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 120 mcg / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic kidney disease (ckd).
ישראל -
עברית -
Ministry of Health
פגלקס תות
neo-life health -care ltd - polyethylene glycol 3350 99.8225 %w/w - powder for suspension - treatment of constipation.
ישראל -
עברית -
Ministry of Health
ארומזין
pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.